Navigation Links
ADHD Medications Don't Pose Cancer Risk
Date:11/21/2008

Study found 2 popular drugs do not cause genetic damage that can lead to disease

FRIDAY, Nov. 21 (HealthDay News) -- Two popular medications for treating attention-deficit hyperactivity disorder (ADHD) do not cause genetic damage linked to an increased risk for developing cancer, a new study says.

The study, done by researchers at Duke University Medical Center and the National Institutes of Health, counters a previous one that reported biomarkers associated with an increased cancer risk were present in the blood of children taking the ADHD drug methylphenidate.

"The new findings should help alleviate some of the concerns that were raised by the previous study," study co-author Scott Kollins, director of Duke's ADHD program, said in a university news release. "However, we need to continue to study the long-term effects of these medications and expand our analyses to include older patient populations."

The new study, which looked at methylphenidate (Ritalin LA and Concerta) and amphetamine (Adderall and Adderall XR), used a larger study sample and conditions that apply to a wider cross-section of children with ADHD than the initial study did, he said.

"We looked at three common markers associated with damaged chromosomes and did not find increased genetic abnormalities in children taking either medication, regardless of a variety of factors, such as age, sex, body weight, height, race or ADHD subtype," Kollins said.

About 2 million children have ADHD, a condition commonly characterized by inattention, hyperactivity and impulsivity. Methylphenidates and amphetamines have been used to treat the condition for decades, with millions of prescriptions written for them in the United States every year.

The study was published in the November online issue of the Journal of the American Academy of Child & Adolescent Psychiatry.

More information

The U.S. National Institute of Mental Health has more about ADHD.



-- Kevin McKeever



SOURCE: Duke University Medical Center, news release, Nov. 19, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
2. Naturally Safe Cold Remedy Challenges Effectiveness of Over-The-Counter Cold Medications
3. Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications
4. New Google Health Application Helps Users Find Patient Assistance Programs for Medications Using PatientAssistance.com
5. Anti-inflammatory medications may become a treatment for schizophrenia
6. VIDEO from Medialink and Philips: Microbubbles Developed to Administer Medications That Fight Cancer and Reduce Side Effects
7. Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications
8. Researchers examine safety of Internet prescriber service providing erectile dysfunction medications
9. Allergic-like reactions to iodinated contrast material treated safely with commonly used medications
10. Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications
11. National Headache Foundation Offers Statement, Experts on Appropriate Use of Medications for Migraine Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ADHD Medications Don't Pose Cancer Risk
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... ... 2017 , ... In the United States, single-family home owners ... New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 ... property-tax rates, which contributes to the relatively lower cost of living in places ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... The Rebound mobile app is poised to become a vital ... prescription drug addiction. The app empowers users to develop an ... their dosage in a safe, controlled manner while maximizing well-being. ... 100,000 people to sign up will enjoy 3 months of ... ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: